GYL Financial Synergies’s VivoSim Labs VIVS Stock Holding History

GYL Financial Synergies’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-63	Closed	-$4K	–	181
2019 Q3	$4K	Hold	63	–	–	﹤0.01%	168
2019 Q2	$8K	Hold	63	–	–	﹤0.01%	159
2019 Q1	$15K	Hold	63	–	–	0.01%	159
2018 Q4	$14K	Buy	+63	New	+$15.9K	0.01%	143

Other funds holding VIVS

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GYL Financial Synergies's VIVS Position: Q4 2019 in Review

GYL Financial Synergies sold out of VivoSim Labs (VIVS) in Q4 2019, closing a stake of 63 shares — an estimated $4K sold.

GYL Financial Synergies first reported a position in VIVS in Q4 2018 and held it in 4 quarters. The position peaked at $15K in Q1 2019. 78 funds tracked by Wall St. Rank hold VIVS as of Q4 2019.

GYL Financial Synergies reported no remaining VivoSim Labs position as of Q4 2019 after selling out during the quarter.
GYL Financial Synergies sold 63 VivoSim Labs shares in Q4 2019, an estimated $4K.
GYL Financial Synergies first reported a position in VivoSim Labs in Q4 2018 and held it in 4 quarters.
GYL Financial Synergies's VivoSim Labs position peaked at $15K in Q1 2019.
78 funds tracked by Wall St. Rank held VivoSim Labs as of Q4 2019.

Based on GYL Financial Synergies's 13F filing for Q4 2019, filed 6 Feb 2020.